Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chifeng Weikang Biochemical Pharmaceutical is a specialized pharmaceutical manufacturer based in Inner Mongolia, China, focusing on biochemical products derived from animal sources. The company is a significant producer of anticoagulant APIs and finished products, including Heparin Sodium and low molecular weight heparins such as Enoxaparin and Dalteparin. Beyond anticoagulants, their portfolio features essential enzymes and proteins like Trypsin, Chymotrypsin, and Cytochrome C, used in various clinical applications. Chifeng Weikang operates under stringent GMP standards, serving as a key supplier in the global biochemical supply chain. Their business model encompasses both the production of high-purity active pharmaceutical ingredients and the manufacture of injectable finished dosages. The company is recognized as a high-tech enterprise and maintains a strong presence in both domestic and international markets for biochemical drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chifeng Weikang Biochemical Pharmaceutical.